Multiple insider selling at Valens Groworks (:VGW)

Andrew Tyler Robson, CEO and Director, disposed of 264,000 Common Shares on a direct ownership basis at prices ranging from $1.950 to $3.063 between December 27th, 2017 and 28th, 2017. This represents a $697,398 divestment of the company's shares and an account share holdings change of -6.7%.

Robert Jacob van Santen, CFO and Director, disposed of 163,066 Common Shares on a control or direction basis for registered holder THE VAN SANTEN FAMILY TRUST at prices ranging from $2.000 to $3.255 between December 27th and 28th, 2017. This represents a $439,792 divestment of the company's shares and an account share holdings change of -5.0%.

John Binder, a 10% Holder, disposed of 25,000 Common Shares on a direct ownership basis at a price of $3.030 on December 28th, 2017. This represents a $75,750 divestment of the company's shares and an account share holdings change of -1.0%.

Valens Groworks is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Valens Groworks Corp, formerly Genovation Capital Corp., is a Canada-based company, which operates as a biotechnology company in the Okanagan Valley of British Columbia. The Company is focused on the cannabis cultivation and research business. The Company's research and development facility is located in Kelowna, British Columbia. The Company provides activities of cultivation, production (extraction), packaging, possession, sale, transportation, delivery and research of medical cannabis.